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Abstract
On the basis of two universal power-law scaling laws, i.e. the scaling dynamic hysteresis in physics and the allometric scaling
metabolism in biosystem, we studied the dynamic response and the evolution of an immunosurveillant anti-tumor system
subjected to a periodic external intervention, which is equivalent to the scheme of a radiotherapy or chemotherapy, within
the framework of the growth dynamics of tumor. Under the modulation of either an abrupt or a gradual change external
intervention, the population density of tumors exhibits a dynamic hysteresis to the intervention. The area of dynamic
hysteresis loop characterizes a sort of dissipative-therapeutic relationship of the dynamic responding of treated tumors with
the dose consumption of accumulated external intervention per cycle of therapy. Scaling the area of dynamic hysteresis
loops against the intensity of an external intervention, we deduced a characteristic quantity which was defined as the
theoretical therapeutic effectiveness of treated tumor and related with the destructive metabolism of tumor under
treatment. The calculated dose-effectiveness profiles, namely the dose cumulant per cycle of intervention versus the
therapeutic effectiveness, could be well scaled into a universal quadratic formula regardless of either an abrupt or a gradual
change intervention involved. We present a new concept, i.e., the therapy-effect matrix and the dose cumulant matrix, to
expound the new finding observed in the growth and regression dynamics of a modulated anti-tumor system.
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Introduction
Dynamic hysteresis is a kind of nonequilibrium phenomenon
and abounds in nature, and it usually occurs in such dynamic
systems as physics, chemistry, mechanics, biology, ecology and so
on. For instance, the collaborative interacting spin system driven
by an external field [1–4], a perturbed mechanical system [5] and
the ecosystem modulated by environmental elements [6–9].
Generally, the dynamic response of a driven system lags behind
the driving force due to the asynchronization between the response
and driving force, which gives rise to a universal dynamic
hysteresis and loop [1]. The area and shape of dynamic hysteresis
loop depend upon the intrinsic factors of a dynamic system as well
as the extrinsic counterparts simultaneously. The main intrinsic
factors include, as for a collaborative interacting spin ensemble,
the coupling intensity and symmetry of spin system; the extrinsic
counterpart is concerned with versatile types of driving forces, e.g.,
a linear or nonlinear driving field, a gradual or an abrupt change
field. Usually, the hysteresis loop area of a dynamic system driven
by its dual field quantifies the energy dissipation of the dynamic
system after a unit cycle of dual field [1], whereas the shape and
symmetry of a loop reflect the symmetry-breaking and restoring of
dynamic ordering in a dynamic system [1,2,10]. Both dynamic
hysteresis and transition provide much insight into a nonequilib-
rium dynamic system, and relevant investigations have been
conducted in plenty since 1990. Among those investigations, the
nonequilibrium dynamic transition, especially the dynamic
hysteresis scaling, becomes the major concern which those
investigators focus on. Generally, the area S of a dynamic
hysteresis loop relates to both the amplitude h and the frequency f
of driving force in a universal power-law form [1,3], i.e.,
S!haf b, ð1Þ
where a and b are two scaling exponents, respectively.
Interestingly as well as importantly, in a biosystem without
external driving there also exists ubiquitously a kind of
spontaneous scaling law, i.e., the well-known allometric scaling
law of metabolism, usually referred to as Kleiber’s law for the
situation of animals and plants, which relates the body mass M of a
living being with its energy consumption Y in a power law as
below:
Y~Y0Mb, ð2Þ
where the Y0 is a normalized prefactor relevant to a specific living
creature, and the letter b is referred to a universal scaling exponent
and actually served as an indicator of classification for different
organisms [11–15]. The power-law scaling rule above reveals
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emerging in a living-being in order to maintain its liveness. As the
fundamental first principle in biology [13], the equation 2 holds
true for both animal and plant species and discloses to some extent
the similarity in their metabolism. For an organism, no matter
what it belongs to, either animals or plants, the essential materials
that the organism needs for sustaining its livingness are supplied
and transported through space-filling fractal networks of branch-
ing tubes, which are of self-similarity and underlie the metabolic
process of an organism [15]. The opinion of fractal networks
mentioned above, however, was argued by Kurz et al [16].
According to the quantity of scaling exponent b, a variety of
metabolic types have been classified as: for most organic species,
the b takes an invariant value of 3/4; the positive 1/4 of b
conforms with the situations of times of blood circulation,
embryonic growth and development, and life-span; the negative
1/4 of b, however, accounts for the rates of cellular metabolism,
heartbeat and maximal population growth [15]. Another classi-
fication regarding the isometric and allometirc scaling types could
be derived from whether b=1or b?1, respectively [14]. According
to Dreyer [17], the origin of a power-law allometric scaling
exponent has been ascribed to the existence of a supply-
distribution system with a central source and a distribution of
sources. A series of recent studies on allometric scaling, both
theoretically and experimentally, present the arguments over the
equation 2 and then revise it by involving more factors such as
temperature, nonlinear term etc. to widely adapt to diverse
biosystems in nature [18–25]. Readers may refer to the recent
general review article for more information [24]. Actually, the
scaling law of spontaneous metabolism in a living being has
attracted the interdisciplinary concern, including biology, ecology,
medicine, physics, mathematics, and so on.
The metabolism of a modulated biosystem, e.g., driven by a
periodic external force, however, usually is adjusted to a certain
rhythm and probably appears a new metabolic regime different
from the spontaneous metabolism mentioned above. The variation
of metabolism, due to the involvement of an external intervention,
even results in some unfamiliar occurrences within a living being.
Owing to the impact of war or disaster, a pregnant female
undergoes a subtle change of metabolic level of incretion within
her body, and she usually gives birth to a babygirl [25]. In the state
of an emergency, enhancement of hormone level prompts the
metabolic regulation in stress. It is of a fundamental significance to
study the metabolic law of a living being, especially when it is
modulated by an external intervention.
We simulated in this study the dynamic response of the
metabolic growth and regression of tumors, which are modulated
by an external periodic intervention similar to the scheme of a
radiotherapy or chemotherapy. The networks of blood vessel, by
analogy with the supply-distribution system of a central source as
Dreyer described [17], act as a pipeline to carry the nutrient to
sustain the growth of a tumor as well as the chemotherapeutant to
kill a tumor, and it relates closely to the metabolism of a tumor
under therapy. Based on the scaling metabolism without an
external intervention described in most references, we focus on the
external periodic intervention and the crucial role it plays on the
metabolism of a tumor under therapy. Fractionated radiotherapy
and chemotherapy are two major methods for the clinic treatment
of cancer patients in advanced stage, and the dynamic regression
and repopulation of cancer cells during treatment have a
substantial impact on the curative effect, the prognosis and the
recurrence and metastasis of cancer [26]. Intriguingly, does a
simple and universal scaling formula exist to quantify the
underlying metabolism between the regression of tumor cells
and the dose consumption in chemotherapy or radiotherapy? The
current paper will answer the question above on the base of our in
silico research. We selected the dynamic differential equation
(DDE) of tumor growth, which is of universality and well-proved
experimentally by the enzyme dynamics [27]. We also introduced
an external intervention term in original DDE to explore its new
feature of dynamic evolution probably activated by an external
intervention.
Results
Figure 1 shows the dynamic hysteresis loops of the tumor
population density x(t) against a rectangular wave h(t) (figure 1(a))
and sinusoidal wave h(t) (figure 1(b)) in a variety of duty-cycles of
therapy, respectively. The dynamic hysteresis loop of a gradual-
change sinusoidal intervention differentiates evidently its abrupt-
change rectangular counterpart in shape and extend. The area of
hysteresis loop S maximize at an intermediate duty-cycle of
therapy d, referred to the dmax, for two sorts of interventions above,
suggesting that the intervention impacts most significantly on the
tumor cells. The abrupt-change rectangular intervention attains its
maximal area at a smaller dmax value (,30%) than its gradual-
change sinusoidal counterpart (,50%). Different external inter-
ventions do not alter the trend of the S versus the d other than the
value of the dmax. The maximal area of hysteresis loop signifies the
realization of the most obvious destructive metabolic effect
(apoptosis of treated tumor cells) along with the dose consumption
of external intervention, viz. the most effective interplay between a
medicament and the treated tumors. The dynamic hysteresis loop
of the tumor population density against an intervention in figure 1
also indicates that the dynamic growth and regression of a tumor
system, when modulated by an external intervention, is charac-
terized by a sort of hysteretic metabolism.
Figure 2 depicts the dependence of average tumor population
density ,x. on the dose cumulant of intervention I per cycle, and
the dose-effect relationship, i.e. I vs ,x., takes on a typical
sigmoidal trend which is ubiquitous in biology and medicine.
Larger dose cumulant I entails the decline of tumor cells, achieving
a better treatment effect. Note that on the dose-effect curve there is
a optimal dose cumulant IO (marked with a down-arrows) above
which the average population density of treated tumors ,x.
maintains a quite low level and the dose cumulant affects the ,x.
slightly. Increasing the duty-cycle of therapy d leads to a distinctive
decline of average population density ,x., but the declining
trend, as demonstrated in the inset of figure 2, becomes obviously
slight while the d is greater than a certain value to which we refer
as the effective duty-cycle of therapy de (marked with several down-
arrows in inset). The effective duty-cycle of therapy de is no longer
observed in the case of small amplitude. Larger amplitude of
intervention gains a smaller de, indicating that an extended
recovery period is necessary after a high-intensity treatment, which
is in agreement with the common situation of clinic tumor therapy.
It is also observed, according to the dot line in figure 2, that the
largest derivative d,x./dI attains in the intermediate range of
dose cumulant I, namely the tumor population density declines
most drastically, an evidence that the destructive metabolic
apoptosis of treated tumor cells occurs most significantly with a
certain intermediate cumulant of dose consumption. Notice that
the consistency that an intermediate duty-cycle of therapy d yields
the largest area of dynamic hysteresis loop S as much as an
intermediate dose cumulant I gives rise to the largest derivative
d,x./dI.
The dynamic hysteresis loop contains the general information of
the variation of treated tumors and the modulation of interven-
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relation of the apoptosis of treated tumor cell x(t) with the dose
consumption of medicament h(t) effecting on tumor cells within a
period of treatment. Scaling the area of hysteresis loop S against
the various amplitudes of external intervention h0 from 0.1 to 1.0,
we could work out the basic scaling trend of destructive metabolic
apoptosis of treated tumors with a sort of intervention, and
estimate relevant treatment capacity. The scaled area of hysteresis
loop with amplitude h0, which we set Y=S/h0, signifies the
variation, or more precisely a sort of destructive metabolism, of
tumors subject to the intervention. Figure 3(a) and (b) show the
profiles of the destructive metabolic apoptosis of treated tumors Y
versus different kinds of dose cumulant of sinusoidal (a) and
rectangular intervention (b) I per cycle, respectively, while the
amplitudes of intervention h0 range from 0.1 to 1.0. Rescaling the
data of figure 3 (a) and (b) with the quadratic conversion of
equation 3.1 and then reducing the rescaled data with equation
3.2,3.3, we could further figure out the reduced form of the
rescaled data Y’ vs. I’ and the figure 3(c) displays the reduced data
of both sinusoidal and rectangular intervention as well as the
quadratic fitting curve of the reduced data. The trend of rescaled
data Y’ vs. I’ of two sorts of interventions, regardless of either a
gradual or abrupt change, resembles each other considerably and
reaches its maximum at an intermediate reduced dose consump-
tion cumulant about I’=0.4. The rescaled data could be well fitted
in a quadratic formula by least square approximation as below:
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where the symbol i denotes different values that the amplitude of
intervention h0 takes from 0.1 to 1.0, and the symbol j signifies
various values that the duty-cycle of therapy d takes from 0.1 to
0.9; the combination of i and j is a matrix (9 columns, 10 rows
currently) which we refer to as the dose cumulant matrix Iij since it
contains both the intensity h0 and the duration d of dose. The Yij is
referred to as the therapy-effect matrix and it functionally depends
on the dose cumulant matrix Iij, expressed as Yij=F (Iij) in brief.
Discussions
In comparison with those preceding studies, the finding in
current work is the new feature of a modulated anti-tumor system
on the dynamic scaling hysteresis of dose-effectiveness: firstly, the
most evident therapeutic effect Y occurs at an intermediate dose
cumulant I; secondly, the dynamic scaling relation of dose-
effectiveness complies with a quadratic-formula instead of the
usual power-law form.
For the sake of simplicity physically and biologically, we
assumed that merely the dose consumption of the dose
accumulation I contributes to the destructive metabolic apoptosis
of treated tumor cell, a simplicial causality of dose-effectiveness
which underlies the study. As per the assumption, the destructive
metabolic apoptosis of treated tumor cell is regarded as equivalent
to the therapeutic effect Y, and it is easy to account for the reason
why the most evident therapeutic effect occurs at an intermediate
dose cumulant I. When the duty-cycle of therapy (or dose
cumulant) is small, the lower therapeutic intensity can not afford to
destroy the tumor cells substantially. Contrarily, the low level of
tumor density under a quite large duty-cycle of therapy, as shown
in figure 1, can not provide sufficient tumor cells to be treated,
leading to a poor therapeutic effectiveness as well.
The result in figure 3(c) connotes somewhat a new sort of
universal dynamic characteristic of an immunosurveillant anti-
tumor system subject to two sorts of periodic external interventions
which imitate the scheme of either a radiotherapy or chemother-
apy. In spite of quite distinctive periodic external interventions
involved, an intriguing universal quadratic-formula scaling
relation that correlates the therapeutic effectiveness Y with the
dose cumulant I was observed in the modulated anti-tumor system
when both of them are scaled and reduced. The current anti-
tumor model differentiates those models we mentioned above in
two aspects. Intrinsically, the anti-tumor system in nature, or more
generally a bio-system, can not probably behave with exact duality
Figure 1. The dynamic hysteresis loops of the population
density of treated tumors x(t). (A) an abrupt-change intervention
(rectangular-wave) h(t), (B) a gradual-change intervention (sinusoidal-
wave) h(t).
doi:10.1371/journal.pone.0016115.g001
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equation 1. Extrinsically, unlike the spontaneous metabolism of a
static bio-system without introducing any modulations as present-
ed in equation 2, the current anti-tumor system is modulated
dynamically by an intervention. We attributed the dynamic
quadratic-formula scaling relation of the anti-tumor system to two
new features mentioned above.
Conclusions
The immunosurveillant anti-tumor system, when modulated
periodically by either an abrupt- or gradual-change external
intervention simulating the scheme of a radiotherapy or
chemotherapy, exhibits the hysteretic dynamic response to the
external intervention. The area of dynamic hysteresis loop
characterizes a sort of dissipative-therapeutic relationship of the
dynamically responding tumors under treatment with the dose
consumption of accumulated external intervention per cycle of
therapy. Through scaling approach, we worked out the theoretical
therapeutic effectiveness of treated tumor, and found out that the
scaled dose-effectiveness, namely the dose cumulant per cycle of
intervention versus the therapeutic effectiveness, obeys a universal
quadratic rule regardless of either an abrupt or gradual change
intervention involved. The most evident therapeutic effect occurs
at an intermediate dose cumulant of therapy. We also presented a
new concept, i.e., the therapy-effect matrix and the dose cumulant
matrix, to expound the new finding observed in the growth and
regression dynamics of a modulated anti-tumor system.
Methods
Concerning the growth and regression of tumor cells under
immune surveillance against cancer, the dynamic transition
between the normal and tumor cells can be modeled by the
enzyme dynamic process and expressed schematically as below
[27]:
Figure 2. The dependence of average population density of treated tumors ,x. on the dose cumulant of intervention I as well as
the relevant first derivative d,x./dI per cycle. (A) sinusoidal and, (B) rectangular intervention in variety of the amplitudes of intervention h0.
Inset: ,x. versus the duty-cycle of therapy d.
doi:10.1371/journal.pone.0016115.g002
Dynamic Response and Metabolism in a Tumor System
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e16115Normal Cells {  ?
c
X, X {  ?
l
2X,
XzE0 {  ?
k1 E {  ?
k2 E0zP, P {  ?
k3 ,
ð4Þ
in which the symbols X, P, E0 and E symbolize cancer cells, dead
cancer cells, immune cells and the compound of cancer cells and
immune cells, respectively; the symbols c, l,k 1,k 2 and k3 are
velocity coefficients. The above transition, which underlies our
current study, indicates that normal cells may transform into
cancer cells, and then the cancer cells reproduce, decline and die
out ultimately. An equivalent single-variable deterministic dynam-
ics differential equation, i.e., the well-established Logistic equation,
can be derived from this model [28],
dx
dt
~ax{bx2{Q(x), ð5Þ
where the x(t) and the t are the population density of tumor and
the evolution time, respectively; the coefficients a and b stand for
the linear per-capita growth rate of tumor cells and the carrying
capacity of the environment, respectively. Term Q(x) quantifies the
abilities of recognizability and attack which the immune cells act
on the tumor cells, and its form is usually adopted as bx
2/(e+x
2)
[28]. Here, the parameter b and e are the immune coefficient and
the threshold at which the immune system initiates. A periodic
external intervention h(t) which imitates a clinic therapeutic
schedule was added in equation 5 and the final dynamic
differential equation was rewritten as follows:
dx
dt
~ax{bx2{
bx2
ezx2 {h(t):x, ð6Þ
where the periodic external intervention h(t) takes the form of
either an abrupt change (rectangular wave) for radiotherapy or
gradual change (sinusoidal wave) for chemotherapy, respectively,
as illustrated in figure 4. The symbol h0 denotes the amplitude of
an external intervention, similar to the clinical therapy intensity of
either chemotherapy or radiotherapy. The duration from 0 to T is
defined as one cycle of treatment, and two partial durations, 0,T0
and T0,T, are designated for the drug-taking and drug-
suspending period, respectively. In the light of the ratio of drug-
taking versus drug-suspending duration, we defined a new
frequency-like characteristic parameter, d=(T 0/T)6100%, as
the duty-cycle of therapy. Actually, the parameter h0 and d here
are equivalent to h and f, respectively, in figure 2. The integral of
Figure 3. The destructive metabolic apoptosis of treated tumors S/h0 versus different dose cumulants of intervention I per cycle.
The amplitude of intervention h0 ranges from 0.1 to 1.0. The open symbol (A) and solid symbol (B) were plotted singly for sinusoidal and rectangular
intervention, respectively. The figure (C) represents the combined plot of rescaled data from the profiles of figure (A) and (B) by a quadratic
conversion with a quadratic fitting curve, and the parameters in the table are fitting constants.
doi:10.1371/journal.pone.0016115.g003
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dose cumulant of sinusoidal (rectangular) wave within a cycle of
treatment. We approached the equation 6 through numerical
simulation, and worked out the solutions concerning the evolution
of tumor population density x(t), the time-average x(t) per cycle
,x(t)., and the extent of x(t) ranging from its maximum to
minimum Dx.
Declaration of the value which these parameters take in our
simulation: Throughout this paper we set a=1.0, b=0.10, b=1
and e=1. The therapy intensity h0 and the duty-cycle of therapy d
are given in relevant plots, respectively.
For the sake of simplicity, the treatment of tumors could be
theoretically simplified as two basic processes: the apoptosis of
tumor cells under treatment, regarded also as a kind of destructive
metabolic process; the dose consumption of cumulative medica-
ment, functioning as a kind of dissipation. Generally, medicament
exerts its influence to tumor cells, and the dose consumption leads
to the destructive metabolic apoptosis of treated tumors. Ideally,
we assumed that the tumors under therapy are only treated by the
external intervention (medicament), and therefore it is feasible for
us to simply focus on the simplicial causality between the
destructive metabolic apoptosis of treated tumors and the dose
consumption. Because of the dynamic delay generally in nature,
the response of tumor population density x(t) to an external
intervention h(t) lags behind in phase, giving rise to a dynamic
hysteresis loop of x(t) versus h(t) as shown in figure 1. The dynamic
hysteresis loop of x(t) versus h(t), however, could not be taken for
the dissipated energy as usually in a thermodynamic system in that
the tumor population density x(t) and the external intervention h(t)
themselves can not relate to each other in duality essentially. As
what the biochemical experiment demonstrates, the energy
metabolism during the apoptosis of cell lines is complex and
influenced by numerous factors [29]. Considering physically and
biologically, we deem that the dynamic hysteresis above implies a
sort of metabolic relation of the apoptosis of treated tumor cell x(t)
with the consumption of medicament h(t) effecting on tumor cells
within a period of treatment. The area of dynamic hysteresis loop
S within a period T was figured out as below
S~
þ
T
x(t):h(t)dt ð7Þ
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